Photos have not been retouched. Individual results may vary.
Patients in the ONEXTON clinical trial were 12 years of age and older with moderate-to-severe acne. This means they had anywhere between 20-40 pimples or 20-100 whiteheads and/or blackheads before they started the trial. During the trial, patients applied either ONEXTON Gel or a gel with no other medication once a day for 12 weeks.
Many patients see significant results at 12 weeks with ONEXTON.
To get the best results, apply regularly as directed by your doctor.
ONEXTON® (clindamycin phosphate and benzoyl peroxide) Gel, 1.2%/3.75% is a prescription medicine used on the skin (topical) to treat acne vulgaris in people 12 years and older.
Do not use ONEXTON Gel in your mouth, eyes, or vagina. It is not known whether ONEXTON Gel is safe and effective for use longer than 12 weeks, or in children under 12 years of age.
Do not use ONEXTON Gel if you have: